Cao Liwei

Dr. Cao Liwei is an Associate Professor and Doctoral Supervisor at Southern University of Science and Technology's School of Medicine. He obtained his B.S. in 2009 from East China University of Science and Technology and PhD in 2014 from Dalian Institute of Chemical Physics. After postdoctoral training at The Scripps Research Institute and Johns Hopkins University, he established his research group at SUSTech in 2022.

• B.S. (2009) - East China University of Science and Technology
• PhD (2014) - Dalian Institute of Chemical Physics, CAS
• Postdoc (2014-2019) - Scripps Research Institute
• Postdoc (2019-2022) - Johns Hopkins University
• Current: Associate Professor at SUSTech School of Medicine

Dr. Cao's research focuses on proteogenomics-based cancer pathogenesis and quantitative protein glycosylation analysis with applications in HIV vaccine development. His work develops cutting-edge mass spectrometry methods for glycoprotein characterization, particularly in pancreatic cancer and viral envelope proteins.

Recent trends in his publications show expertise in glycan processing analysis (10 papers), proteogenomic tumor characterization (4 papers), and chromatographic method development (3 papers). Key collaborations include Clinical Proteomic Tumor Analysis Consortium and HIV vaccine development teams.

• 2022 - Johns Hopkins Young Investigator Award
• 2018 - Scripps CHAVI-ID Young Investigator Award
• 2014 - Yanchang Petroleum Outstanding Doctoral Award

He has trained multiple advisees through his cancer proteomics research group at SUSTech, with funding from national research consortiums. His laboratory develops glycoproteomic technologies for clinical applications and maintains partnerships with leading US research institutions.